Averywell Company Profile: Funding, Investors & Partnerships

Averywell

Averywell revolutionizes late-stage lung cancer diagnosis in the UK with a groundbreaking miRNA-based liquid biopsy. Our non-invasive, precise, and cost-effective technology ensures early detection, enabling timely treatment access for smokers and non-smokers.Averywell revolutionizes late-stage lung cancer diagnosis in the UK with a groundbreaking miRNA-base Show More

Alpha Score

39.2